Диссертация (Медицинские ошибки при применении бета-лактамных антибиотиков), страница 22

Harrold et al. // JAMA. 2003. - №289. - P. 1107 - 1116.108. Influence of attitudes on pharmacists' intention to report serious adverse drugevents to the Food and Drug Administration / P. Gavaza, C. M. Brown, K. A.Lawson et al. // Br J Clin Pharmacol. - 2011.

- Vol. 72. - №1. - P. 143 - 152.133109. Investigating the prevalence and causes of prescribing errors in generalpractice: ThePRACtICe Study (PRevalence And Causes of prescribing errors ingeneral practiCe). A report for the General Medical Council / Т. Avery, N.Barber, M. Ghaleb et al. - 2012. - 22 - 162 p.110. Jeetu, G. Prescription Drug Labeling Medication Errors: A Big Deal forPharmacists / G. Jeetu, T. Girish // J Young Pharm. - 2010. - Vol. 2. - №1.

- P.107 – 111.111. Kohn, L. T. To Err is Human: Building a Safer Health System / L. T. Kohn, J.M. Corrigan, M. S. Donaldson. - Washington (DC): National Academies Press(US), 2000. - 26 p.112. Kollef, M. H. Appropriate Empiric Antimicrobial Therapy of NosocomialPneumonia: The Role of the Carbapenems / M. H. Kollef // J Respir Care. 2004.

- Vol. 49. - №12. - P. 1530 - 1534.113. Kumar, A. Optimizing antimicrobial therapy in sepsis and septic shock / A.Kumar // Crit Care Clin. - 2009. - Vol. 25. - №4. - P. 733 - 751.114. Lambert, P. A. Pharmaceutical quality of ceftriaxone generic drug productscompared with Rocephin / P. A. Lambert, B. R. Conway // J.

Chemother. - 2003.- №15. - P. 357 - 368.115. Lansita, J. A. The development of therapeutic monoclonal antibodies:overview of the nonclinical safety assessment / J. A. Lansita, B. Mounho-Zamora// Curr Pain Headache Rep. - 2015. - Vol. 19. №2. - P. 2.116. Lexchin, J. Is there still a role for spontaneous reporting of adverse drugreactions? / J.

Lexchin // CMAJ. - 2006. - Vol. 174. - №2. - P. 191 – 192.117. Lindbaek, M. Prescribing antibiotics to patients with acute cough and otitismedia / M. Lindbaek // British Journal of General Practice. – 2006. – Vol. 56. –№ 524. – P. 164 - 166.118.

Linder, J. A. Antibiotics for Treatment of Acute Respiratory Tract Infections:Decreasing Benefit, Increasing Risk, and the Irrelevance of AntimicrobialResistance / J. A. Linder // Clin Infect Dis. - 2008. - №47. - P. 744 – 746.134119. Matvieiev, O.V. Adverse reactions in children are not the same in adults:Analysis of spontaneous reports in 2011-2012 in Crimea, Ukraine / O. V.Matvieiev // Clinical Therapeutics. - 2013. - №35.

- Suppl. 8. - е90 - 91.120. Medication errors and adverse drug events in pediatric inpatients / R. Kaushal,D. W. Bates, C. Landrigan et al. // Journal of the American Medical Association.- 2001. - Vol. 285. - №16. - P. 2114 – 2120.121. Medication Errors Associated With the Use of Beta-Lactam Antibiotics inRussian Federation / S. Zyryanov, I.

Asetskaya, A. Kuzmina, V. Polivanov //Open Forum Infectious Diseases. – 2016. – Vol. 3. – Issue suppl. 1. – Р. 984.122. Medication Errors In Relation To Education and Medication Errors InRelation To Years of Nursing Experience /C. G. Bailey, B. S. Engel, J. N.Luescher, M. L.Taylor // For Dr. Maranah Sauter’s Nursing Resarch course.

2008. - Vol. 3. - P. 1 - 8.123. Medication errors observed in 36 health care facilities / K. N. Barker, E. A.Flynn, G. A. Pepper et al. // Archives of Internal Medicine. - 2002. - Vol. 162. №16. - P. 1897 – 1903.124. Medication Errors Related to Drugs [Электронный ресурс] // U. S. Food andDrugAdministration.-Режимдоступа:https://www.fda.gov/drugs/drugsafety/medicationerrors/125. Medication errors in hospitalised children / E. Manias, S. Kinney, N.Cranswick, A.

Williams // J Paediatr Child Health. - 2014. - Vol. 50. - №1. - P.71 - 77.126. Medication knowledge, certainty, and risk of errors in health care: a crosssectional study / B. J. Simonsen, I. Johansson, G. K. Daehlin et al. // BMC HealthServices Research. - 2011. - №11. - P. 175.127. Misurski, D.A. Inappropriate Antibiotic Prescribing in Managed CareSubjects with Influenza / D.A.

Misurski, D.A. Lipson, A.K. Changolkar // TheAmerican Journal of Managed Care. – 2011. – Vol. 17. – № 9. – P. 601 -608.135128. Navarro, V. J. Drug-Related Hepatotoxicity / V. J. Navarro, J. R. Senior // NEngl J Med. - 2006. - №354. - P. 731 - 739.129. Nightingale, C. H. A survey of the quality of generic clarithromycin productsfrom 18 countries / C.

H. Nightingale // Clin Drug Investig. - 2005. - №25. - P.135 - 152.130. Non-prescription antimicrobials use worldwide: a systematic review / D. J.Morgan, I. N. Okeke, R. Laxminarayan, E. N. Perencevich // Lancet Infect Dis. 2011. - Vol.

11. - №9. - P. 692 – 701.131. Out-of-hospital medication errors among young children in the United States,2002-2012 / M. D. Smith, H. A. Spiller, M. J. Casavant et al. // Pediatrics. - 2014.- Vol. 134. - №5. - P. 867 - 876.132. Overcoming the barriers to the uptake of nonclinical microsampling inregulatory safety studies / K. Chapman, S. Chivers, D. Gliddon et al.

// DrugDiscov Today. - 2014. - Vol. 19. - №5. - P. 528 - 532.133. Overuse of antibiotics for the common cold – attitudes and behaviors amongdoctors in rural areas of Shandong Province, China / Q. Sun, O.J. Dyar, L. Zhaoet al. // BMC Pharmacol Toxicol. – 2015. – Vol. 16. – P. 6.134. Overview of seizure-inducing potential of doripenem / G. G. Zhanel, N.Ketter, E. Rubinstein et al. // J Drug Saf. - 2009.

- Vol. 32. - №9. - P. 709 - 716.135. Paludetto, M. N. Is spontaneous reporting always the most importantinformation supporting drug withdrawals for pharmacovigilance reasons inFrance? /M. N. Paludetto, P. Olivier-Abbal, J. L. Montastruc //Pharmacoepidemiol Drug Saf. - 2012. - Vol. 21.

- №12. - P. 1289 - 1294.136. PINCER trial: a cluster randomised trial comparing the effectiveness and costeffectiveness of a pharmacist-led IT-based intervention with simple feedback inreducing rates of clinically important errors in medicines management in generalpractices. A report for the Department of Health Patient Safety Research Portfolio/ A. J. Avery, S. Rodgers, J. A. Cantrill et al. - 2010. - 195 p.136137. Poole, R. L. Medication Errors: Neonates, Infants and Children Are the MostVulnerable! / R. L. Poole, B.

C. Carleton // J Pediatr Pharmacol Ther. - 2008. Vol. 13. - №2. - P. 65 – 67.138. Predictors of inappropriate antibiotic prescribing among primary carephysicians / G. Cadieux, R. Tamblyn, D. Dauphinee et al. // CMAJ. - 2007. - Vol.177. - № 8.

- P. 877 - 883.139. Preventing Medication Errors: Quality Chasm Series /P. Aspden, J. A.Wolcott, J. L. Bootman et al. - Washington DC: National Academies Press, 2007.- 92 - 97 p.140. Relationship between medication errors and adverse drug events / D. W.Bates, D. L. Boyle, M. B. Vander Vliet et al. // J Gen Intern Med. - 1995. - №10.- P. 199 – 205.141.

Reporting and learning systems for medication errors: the role ofpharmacovigilance centres // World Health Organization. - WHO LibraryCataloguing-in-Publication Data, 2014. - 28 - 40 p.142. Research Priority Setting Working Group of the WHO World Alliance forPatient Safety. Patient safety research: an overview of the global evidence / A. K.Jha, N.

Prasopa-Plaizier, I. Larizgoitia et al. // Qual. Saf. Health Care. - 2010. Vol. 19. - №1. - P. 42 - 47.143. Resolution EB109. R16 Quality of Care: Patient Safety // World HealthOrganization, 2002.144. Ruiz, M.E. Risks of self-medication practices / M. E. Ruiz // Current DrugSafety. - 2010. - Vol. 5. - №4. - P. 315 - 323.145. Surviving Sepsis Campaign: International Guidelines for Management ofSevere Sepsis and Septic Shock: 2012 / P. R.

Dellinger, M. M. Levy, A. Rhodeset al. // Crit Care Med. - 2013. - Vol. 41. - №2. - P. 580 - 637.146. SWAB guidelines for Antibacterial therapy of adult patients with Sepsis / I. C.Gyssens, H. I. Bax, E. F. Schippers et al. - Stichting werkgroep antibioticabeleid,2010. - 59 - 67 p.137147. Tackling medication errors: European Medicines Agency workshop calls forcoordinated EU approach. Press release [Электронный ресурс] // EuropeanMedicinesAgency.-2013.-Режимдоступа:http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/03/news_detail_001729.jsp&mid=WC0b01ac058004d5c1148. The Adverse Drug Reactions from Patient Reports in Social Media Project:Five Major Challenges to Overcome to Operationalize Analysis and EfficientlySupport Pharmacovigilance Process / C.

Bousquet, B. Dahamna, S. GuilleminLanne et al. // JMIR Res Protoc. - 2017. - Vol. 6. - №9. - e179.149. The incidence and nature of prescribing and medication administration errorsin paediatric inpatients / M. A. Ghaleb, N. Barber, B. D. Franklin, I. C. Wong //Arch Dis Child. - 2010. - №95. P. 113 – 118.150. The use of evidence in pharmacovigilance. Case reports as the referencesource for drug withdrawals / J. A. Arnaiz, X.

Carné, N. Riba et al. // Eur J ClinPharmacol. - 2001. - Vol. 57. - №1. - P. 89 - 91.151. Tools for Measuring and Improving the Quality of Reports in NationalAdverse Drug Reactions Databases [Электронный ресурс] // The StrengtheningCollaboration for Operating Pharmacovigilance in Europe. - 2017.

- 23 - 28 p. Режим доступа: http://www.scopejointaction.eu/_assets/files/WP4-DEL8-Toolsfor----Quality-of-ADR-Reports.pdf152. Valanciene, G. Pathogenesis and treatment modalities of localizedscleroderma / G. Valanciene, D. Jasaitiene, S. Valiukeviciene // Medicina(Kaunas). - 2010. - Vol. 46. - №10. - P. 649 - 656.153. Vere, D.W. Drug adverse reactions as masquereders / D. W. Vere // AdverseDrug React Bull. - 1976. - №60.

- P. 208 – 211.154. VigiLyze [Электронный ресурс] // Uppsala Monitoring Centre. - Режимдоступа: https://vigilyze.who-umc.org155. vigiMethods [Электронный ресурс] // Uppsala Monitoring Centre. - Режимдоступа: https://www.who-umc.org/vigibase/vigilyze/vigimethods/138156. Vlahović-Palčevski, V. Postmarketing surveillance / V.

Vlahović-Palčevski,D. Mentzer // Handb Exp Pharmacol. - 2011. - №205. - P. 339 - 351.157. Waller, P. An introduction to pharmacovigilance / P. Waller. - Oxford, UK,John Wiley & Sons, 2010. - 1 p.158. WHO launches global effort to halve medication-related errors in 5 years[Электронный ресурс] // World Health Organization.

- 2017. - Режим доступа:http://www.who.int/mediacentre/news/releases/2017/medication-relatederrors/en/159. WHO Pharmaceuticals Newsletter №3, 2007 // World Health Organization. WHO Press, 2007. - 1-2 p..